A recent study published in NEJM AI highlights Therabot, an AI-powered chatbot that significantly improves symptoms of major depressive disorder (MDD), generalized anxiety disorder (GAD), and eating disorders in just two months. Conducted by Dartmouth researchers, this randomized controlled trial is a pioneer in demonstrating the effectiveness of a fully generative AI therapy chatbot for treating clinically significant mental health symptoms. The functionality of Gen-AI chatbots provides tailored mental health treatments at scale and addresses common engagement challenges found in traditional digital therapeutics.
Generative artificial intelligence (Gen-AI) chatbots hold promise for building highly personalized, effective mental health treatments at scale, while also addressing user engagement and retention issues common among digital therapeutics.
This is the first RCT demonstrating the effectiveness of a fully Gen-AI therapy chatbot for treating clinical-level mental health symptoms.
Collection
[
|
...
]